Irritable bowel syndrome (IBS) is a prevalent and costly condition, with expenditures exceeding US$21 billion annually. As there is no known cure for IBS, treatment is focused on symptom self-management strategies. The purpose of this systematic review was to investigate the efficacy and overall effect of self-management interventions for patients with IBS. Of the 64 publications that were identified, 20 were included in the systematic review. Self-management interventions were found in diverse formats, including web-based, self-training booklets, individual and/or group interventions with health care providers, and cognitive-behavioral therapy or exercise-based interventions. Different symptom measures were used across the studies, whereas measurement of quality of life was more standardized. Overall, there is robust evidence supporting self-management interventions for improving short-term symptom management and improving quality of life, whereas longer term outcomes are variable. Further studies are needed to
use standardized symptom measures and tailor interventions for pediatric populations, and tracking longer term outcomes.
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Irritable bowel syndrome (IBS) is common with prevalence reaching over 20% in some regions of the world, and affects more women than men (Canavan, West, & Card, 2014; Lacy, Chey, & Lembo, 2015; Longstreth et al., 2006) . Direct costs of care and lost productivity in the U.S. exceed US$21 billion annually, and individuals with IBS utilize more health care services than the general population, including outpatient visits, diagnostic testing and over-the-counter and prescription medications (Longstreth et al., 2003; Tang, Yang, Liang, et al., 2012; . Intense, recurrent abdominal (visceral) pain is a predominant symptom of IBS, a functional gut disorder that typically manifests in the early adult years (Lacy et al., 2015; Longstreth et al., 2006) . While women report more severe IBS-related pain, both younger men and women report more severe pain compared with older adult cohorts (Tang, Yang, Liang, et al., 2012; . Individuals with IBS-related pain report that pain is the most distressing symptom and has the greatest impact on quality of life (Lacy et al., 2015) . Although pharmacological interventions are available, individuals often endure a long and frustrating course of learning how to manage pain on their own accord (Frissora & Koch, 2005) .
IBS-related pain is associated with sensitization of the central nervous system, and approximately half of all patients with IBS have visceral hypersensitivity (Frissora & Koch, 2005; Kanazawa, Hongo, & Fukudo, 2011; Whitehead, Palsson, & Jones, 2002) . These alterations in pain processing escalate pain perception in individuals with IBS, and can increase vulnerability to other comorbid pain disorders, including fibromyalgia, chronic fatigue syndrome and chronic pelvic pain (Hulisz, 2004) . As a predominant symptom of IBS, mechanisms of visceral pain have been studied, including neuroendocrine-immune alterations and dysregulation of the gut microbiota (Hughes et al., 2013; Kerckhoffs et al., 2009; Rajilic-Stojanovic et al., 2011; Simren et al., 2013) . Although the findings from these studies have not been conclusive, it is known that the IBS subtype (based on the individual's bowel pattern) can influence the severity, frequency and duration of pain (Saad et al., 2010) . Treatment for IBS is based on the dominant bowel-related symptoms, which is categorized by the following subgroups: IBS with diarrhea (IBS-D), IBS with constipation (IBS-C), and IBS with mixed or alternating diarrhea and constipation (IBS-M; Saad et al., 2010) . However, regardless of subgroup type, which often fluctuates over time (Saad et al., 2010) , individuals with IBS exhibit heightened awareness of pain and alterations in pain processing that directly influence pain perception, the most distressing symptom associated with this condition.
As there is no known cure for IBS, treatment is aimed at symptom selfmanagement (SM; Agency for Healthcare Research and Quality [AHRQ], 2014) . In general, treatment consists of medications to decrease cramping, bloating, diarrhea, constipation, anxiety, and depression, as well as dietary modifications, exercise and stress-reduction (Chang, Lembo, & Sultan, 2014; Trinkley & Nahata, 2014) . Symptom SM plays a large role in helping individuals with IBS to effectively adapt and improve their quality of life. However, SM programs differ regionally and among institutions, which may lead to outcome variability. In addition, it is currently unclear which components of an SM program are most effective for improving SM behaviors, including symptom SM. Therefore, we performed a systematic review of available publications on SM interventions for IBS to answer the following questions: (a) What theoretical models have been used to design SM pro- 
Method
The systematic review was guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement (Moher, Liberati, Tetzlaff, Altman, & PRISMA Group, 2009 ). An extensive literature search of CINAHL, PubMed, PsychINFO databases was conducted to identify primary research articles that focused on evaluating SM programs for IBS patients. Terms used to identify relevant research articles included "Irritable Bowel Syndrome," "IBS," "chronic abdominal pain," "self-management," and "self-efficacy." The MeSH terms "Irritable Bowel Syndrome" and "Irritable Bowel Syndrome/prevention and control" were included in the search on PubMed. Inclusion criteria included (a) primary research articles, (b) published within the last 10 years (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) which was a time span in which SM emerged in the research literature, (c) articles focused on evaluation of SM programs for individual with IBS, (d) confirmed diagnosis of IBS from the research participant's health care provider, and (e) written in English. There was no limit put on age, duration of IBS symptoms, or country in which the research was conducted. Articles were excluded if they were a secondary analysis reporting on a previously reported study sample, reviews, study protocols which have yet to yield results, theses and/or case studies. To reduce review bias, the second and third authors independently searched, screened, and extracted studies in compliance with eligibility criteria. The other primary review members (the first and fifth authors) were asked to arbitrate and independently assessed each included study for evaluating risk of bias.
Search results are depicted in Online Supplementary Figure 1 in concordance with PRISMA guidelines. Upon initial search of the databases 62 articles were found. Of the 62 articles, four were duplicates and 58 were identified as being relevant to the proposed research questions by preliminary review. Upon full inspection of the abstracts, 20 did not meet the prescribed inclusion criteria and were thus excluded. Upon careful inspection of each article, 18 did not meet inclusion criteria and were thus eliminated as well. Methodological appraisal was performed and of the 20 articles that remained all had sufficient strength and appropriate rigor. In total, there were 20 articles included within this systematic review (Online Supplementary Figure 1 and Tables 1-4) .
Results
Description of Study Locations and Designs
Of the identified studies, 10 were conducted in the United States (Dorn et al., 2015; Hunt, Moshier, & Milonova, 2009; Jarrett et al., 2016; Jarrett et al., 2009; Labus et al., 2013; Lackner et al., 2008; Sanders, Blanchard, & Sykes, 2007; Shahabi, Naliboff, & Shapiro, 2016; van Tilburg et al., 2009; Zia, Barney, Cain, Jarrett, & Heitkemper, 2016) , four in the United Kingdom (Everitt et al., 2013; Kennedy et al., 2013; Moss-Morris, McAlpine, Didsbury, & Spence, 2010; Robinson et al., 2006) , three in Sweden (Ljotsson et al., 2010; Ljotsson et al., 2011; Ringstrom, Storsrud, & Simren, 2012) , one in Iran (Ghiyasvandian, Ghorbani, Zakerimoghadam, Purfarzad, & Kazemnejad, 2016) , one in the Netherlands (Oerlemans, van Cranenburgh, Herremans, Spreeuwenberg, & van Dulmen, 2011) , and one in Denmark (Pedersen, 2015) . The studies include one descriptive cohort study (Zia et al., 2016) , two quasi-experimental studies (Dorn et al., 2015; Shahabi et al., 2016) , and 17 randomized controlled trials, with a range of sample sizes from 28 to 1,419.
What Theoretical Models Have Been Used to Design SM Programs for IBS?
Most of the studies identified did not refer to an extant theory or framework from which the intervention was designed. The SM process has been referred as an overarching theory in the studies, but they do not provide specifics on the mechanisms that are being targeted by the intervention. For instance, Moss-Morris et al. (2010) developed a manualized SM intervention, but no further details are provided on the content or mechanisms (i.e., self-efficacy, self-regulation skills, monitoring, etc.). Pedersen (2015) specified the SM intervention as targeting patient education, adherence to medication and access to care providers. Dorn et al. (2015) developed their web-based intervention from a patient needs assessment, interviews with experts and patients, and a systematic review of SM interventions. Jarrett and colleagues (2016) and Jarrett and colleagues (2009) referred to their intervention as based on a biobehavioral theory with components of education and reassurance, diet, relaxation and cognitive-behavioral therapy (CBT). Kennedy et al. (2013) used the normalization process theory to implement a systems-level SM program for IBS. Ljotsson et al. (2010) and Ljotsson et al. (2011) based their intervention on exposure and mindfulness with the focus on acceptance of symptoms, while Ringstrom et al. (2012) referred to the self-efficacy theory and Shahabi et al. (2016) used the social cognitive theory of self-regulation in their interventions.
What Components of SM Have Shown Effectiveness in Reducing IBS Pain and Associated Symptoms?
Internet-based interventions. Studies have used web-based intervention to promote SM behaviors and reduce IBS symptoms (Table 1 ). The SM interventions delivered using a web-based platform over 5 weeks (Hunt et al., 2009 ), 6 weeks (Everitt et al., 2013; Pedersen, 2015) , or 10 weeks (Ljotsson et al., 2010; Ljotsson et al., 2011) were associated with significant improvement in IBS-related symptoms or overall symptoms. Hunt et al. (2009) tested a webbased intervention consisting of five modules and homework and covered management of symptoms and stress, catastrophic thinking, and exposure therapy and showed a significant improvement in symptoms, quality of life, and anxiety in the intervention group compared with the waitlist control group. Everitt et al. (2013) found that symptom severity score decreased and enablement scores increased at follow-ups in the web-based intervention group and the group received nurse-support by phone. Pedersen (2015) monitored IBS symptoms using a web-based platform and found a significant Note. RCT = randomized clinical trial; IBS = irritable bowel syndrome; FBSDI = functional bowel disorder severity index; PAM = patient activation measure; IBS-QOL = irritable bowel syndrome quality of life; IBS-SSS = Irritable Bowel Symptom Severity Scale; SGA of Relief = subjects global assessment of relief; HADS = Hospital Anxiety and Depression Scale; ISM = Internet stress management; GSRS-IBS = Gastrointestinal Symptoms Rating Scale; ASI = Anxiety Sensitivity Index; CPSQ = Consequences of Physical Sensations Questionnaire; VSI = visceral sensitivity index; MADRS-S = Montgomery Asberg Depression Rating Scale-Self Report; LFD = low FODMAP diet;
LGG = probiotic strain Lactobacillus Rhamnosus GG. decrease in overall symptoms. Ljotsson et al. (2010) and Ljotsson et al. (2011) reported that Internet-delivered exposure-based treatment with stress management reduced patients' pain, visceral sensitivity, overall symptoms and disability with increased quality of life. A web-based intervention focused on IBS-related knowledge has been also found to increase patients' knowledge from baseline, but with no effects on self-efficacy or quality of life (Dorn et al., 2015) .
Self-training booklet interventions. Self-care booklets, self-administered manuals, and self-help guidebooks have been found to be effective in reducing severity of symptoms of IBS, increasing quality of life, and promoting work and social functioning ( Table 2) . Ghiyasvandian et al. (2016) used a training booklet, relaxation CD, individual training sessions, and follow-up phone calls in the intervention, and found a significantly reduced severity of symptoms and increased quality of life in the intervention group. Moss-Morris et al. (2010) tested a manualized program in conjunction with face-to-face therapy and phone sessions and reported that more patients in the experimental group experienced symptom relief. Robinson et al. (2006) examined a SM guidebook with focus group meeting or with self-help group meetings, and at 1 year, they found that patients in both guidebook groups had a significant reduction in primary care consultations and perceived symptom severity. Sanders et al. (2007) also examined the effects of a self-help treatment via reading a book based on CBT and normalization of IBS symptoms and found decreased symptom severity at 3-months post-intervention, but with no effect on quality of life. However, one study reported no appreciable differences in self-efficacy or quality of life among patients randomized to receive SM support (self-help guidebook and community resources) for IBS and the waitlist control group (Kennedy et al., 2013) .
Individual and group interventions. Individual SM interventions delivered either in person or by phone were found to be effective in reducing symptom severity and improving quality of life (Table 3; Jarrett et al., 2016; Jarrett et al., 2009; Zia et al., 2016) . Jarrett et al. (2016) and Jarrett et al. (2009) reported that individual sessions incorporating themes of education, diet, relaxation strategies, and CBT significantly reduced patients' abdominal pain and gas, overall symptom severity and work loss, as well as improved their quality of life. Zia et al. (2016) performed a 1-year assessment on the cohort of participants who received the intervention and found that the majority of the participants were still using the strategies learned during the program and adhering to diet composition recommendations and lifestyle behaviors. Group-based SM interventions were also examined and have been found to reduce IBS symptom severity, depression, and catastrophizing (Labus et al., 2013; Ringstrom et al., 2012) . Labus et al. (2013) found that a 5-week group intervention including the bio-psychosocial model of IBS and cognitive-behavioral exercises decreased patients' symptom severity, depression, and catastrophizing, and increased self-efficacy and quality of life. Ringstrom et al. (2012) tested a long version of a SM intervention (6 × 2-hr sessions) led by a multidisciplinary team versus a nurse-led short version (3 × 2-hr sessions) in group format. Although there was no difference over time between groups on the IBS symptom severity, the participants that received the long version had a sustained decrease in depression and anxiety compared with the short version.
CBT or exercise-based interventions. CBT, yoga, guided imagery, and other intervention have also been examined as strategies to improve IBS outcomes (Table 4) . Lackner et al. (2008) examined a standard 10-week CBT group with a minimal contact 4-week self-administered CBT group and found that both groups had decreased symptom severity and increased quality of life compared with the waitlist control group. Oerlemans et al. (2011) examined a 4-week CBT intervention delivered on a digital device and reported that the intervention group had significant improvements in pain, catastrophizing thoughts, and quality of life, but only improvements in catastrophizing thoughts persisted at 3 months.
Therapeutic yoga has been also compared with walking on symptom severity and quality of life. Shahabi et al. (2016) reported that both yoga and walking were significantly effective in reducing severity of IBS symptoms at short-term, while, at 6-months, the walking group showed significant decreases in overall symptoms and was more adherent to self-regulation home practice compared with the yoga group. van Tilburg et al. (2009) tested a home-based guided imagery intervention over 6 weeks in children with IBS and showed significant effects on reducing pain and disability.
What Outcomes Have Been Evaluated in Response to the IBS-SM Program?
SM behaviors. Most of the studies measured SM behaviors using a daily diary Jarrett et al., 2009; Ljotsson et al., 2010; Ljotsson et al., 2011; Oerlemans et al., 2011 ). van Tilburg et al. (2009 Note. RCT = randomized clinical trial; IBS = irritable bowel syndrome; IBS-QOL = irritable bowel syndrome quality of life; IBS-SSS = Irritable Bowel Symptom Severity Scale; WSAS = Work and Social Adjustment Scale; SGA of relief = subject's global assessment of relief; VAS = Visual Analog Scale; VSI = visceral sensitivity index; GHQ-28 = General Health Questionnaire; SF-36 = short form health survey; WRAT = Wide Range Achievement Test-Reading Section; CPSR = composite primary symptom reduction score; BSI = Brief Symptom Inventory; GSRS-IBS = Gastrointestinal Symptoms Rating Scale; SCID-I = structured clinical interview for DSM-IV Axis I. Note. RCT = randomized clinical trial; IBS = irritable bowel syndrome; IBS-SSS = Irritable Bowel Symptom Severity Scale; IBS-QOL = irritable bowel syndrome quality of life; BSI = Brief Symptom Inventory; CSFBD = Cognitive Scale for Functional Bowel Disorders; WPAIQ = Work Productivity and Activity Impairment Questionnaire; CSM = comprehensive self-management; HADS = Hospital Anxiety and Depression Scale; VSI = visceral sensitivity index; CSQ = Catastrophizing Scale Questionnaire; VAS = Visual Analog Scale; FFQ = Food Frequency Questionnaire. Jarrett et al. (2016) , Jarrett et al. (2009), and Oerlemans et al. (2011) . Most of the studies used the Irritable Bowel Syndrome Symptom Severity Scale (IBS-SSS) to measure IBS-related pain, abdominal distension, stool consistency, and general interference with life (Everitt et al., 2013; Ghiyasvandian et al., 2016; Lackner et al., 2008; Moss-Morris et al., 2010) . All the studies measured quality of life using the IBS-QOL, except for five of the studies that did not use the IBS disease-specific tool (Ljotsson et al., 2010; Ljotsson et al., 2011; Moss-Morris et al., 2010; Shahabi et al., 2016; van Tilburg et al., 2009) . Several studies also measured comorbidities of IBS, such as anxiety, depression, and somatization levels using the Brief Symptom Inventory (BSI; Jarrett et al., 2016; Jarrett et al., 2009; Sanders et al., 2007) .
Biomarker measures. Jarrett et al. (2016) measured biomarkers at baseline, including heart rate variability, salivary cortisol, interleukin-10, and lactulose/mannitol ratio to evaluate whether they predicted improvements in the primary IBS outcomes. Heart rate variability has been found to be a significant predictor for SM effects on abdominal pain.
Discussion
The majority of the reviewed studies used a randomized controlled trial design to investigate SM-related interventions on improving IBS outcomes. While some of the studies incorporated interventions that were designed according to well-established behavioral change theories, most of the studies did not mention a theoretical framework; therefore, it was difficult to identify the mechanisms targeted by the interventions and whether it was successful in improving it. For instance, few studies have measured self-regulation although several interventions were developed to improve the self-regulation process. In addition, measurement of health behavior change was not common across studies.
Several groups have developed and tested IBS-SM programs and have found that process factors (IBS knowledge) increase after web-based, individual or group, and telephone interventions (AHRQ, 2014; Chang et al., 2014; Trinkley & Nahata, 2014) ; however, not all have been shown to improve IBS-related pain or SM behaviors for managing symptoms and quality of life (Chang et al., 2014) . In particular, interventions that target mechanisms of IBS-related pain that are individualized to the context and process of pain SM have been recommended (Moher et al., 2009) . Contextual factors of IBS-related pain can influence the individual's SM skills and abilities. Particular to the context of IBS pain, increased stress, pain catastrophizing, and reactivity reduce the ability to engage in pain SM behaviors (physical activity), and due to inability to manage symptoms, result in increased cost of health care services.
SM interventions have been examined in a variety of delivery methods, including Internet-based interventions, self-administered training books, and clinician-guided, individual or group treatment, as well as different amount of time (dose-effect) of the intervention, from 2 to 12 months. Online therapeutic interventions have been found to be efficacious in improving IBS symptoms (Everitt et al., 2013; Pedersen, 2015) . However, whether improvement in IBS symptoms is accompanied by improvements in psychosocial functioning and decreased health care costs remains to be seen. Longer term studies of online interventions for IBS are needed. While online interventions are often more convenient for patients, it may be more difficult to keep the individual engaged in the content and the benefits of social support may not be as accessible (Beatty & Lambert, 2013) . However, they are less costly and may be ideal for improving IBS knowledge and strengthening SM skills. Innovation in the delivery of SM interventions, such as incorporating webbased content delivery with minimal contact as used by Labus et al. (2013) , may enhance translation to clinical practice and improve sustainability of SM intervention delivery in health care systems. Identifying strategies to personalize the interventions for patients with or without access to computers or mobile devices, or who may prefer individual versus group sessions would also be a method for improving patient-centered outcomes.
Symptom severity and disease-specific quality of life measures were fairly uniform across studies, with most studies utilizing IBS-specific symptom assessments. Interestingly, few studies employed biological measures as outcomes. Several secondary analyses were published (not included in the review) to examine differences in biological measures between participants that received the SM intervention and the control group. In IBS patients receiving the SM intervention, urine cortisol (Deechakawan, Cain, Jarrett, Burr, & Heitkemper, 2013) and urine epinephrine and norepinephrine (Deechakawan, Heitkemper, Cain, Burr, & Jarrett, 2014) did not show any appreciable differences despite having lower levels of depression, anxiety, and pain in the experimental groups compared with control groups. Patients with lower nighttime high frequency heart rate variability (vagal modulation) and increased low frequency/high frequency ratio (sympathovagal balance) had less benefit from SM on abdominal pain, while salivary cortisol, IL-10, and lactulose/mannitol ratio were not statistically significant in predicting SM benefit .
Although most of the studies evaluated short-term outcomes over weeks to months, Robinson et al. (2006) , Jarrett et al. (2009) and Ringstrom et al. (2012) included 1-year follow-ups that showed some support for long-term improvement in IBS-related outcomes. A follow-up cohort study by Zia et al. (2016) reported on specific behaviors that were being used by the participants after the study team's well executed SM intervention. Other IBS outcomes have also shown improvement after IBS-SM interventions. In a secondary analysis by the same team, they showed a significant improvement in sexual quality of life of women with IBS (Eugenio, Jun, Cain, Jarrett, & Heitkemper, 2012) . In another secondary analysis, food intake was assessed by Hsueh et al. (2011) who reported increases in fiber and fruit intake with a trend toward increased vegetable intake over 1 year in the intervention group.
Only one study focused on pediatric IBS patients (van Tilburg et al., 2009) . IBS has been diagnosed in 6% to 11% of middle school and high school students using Rome I criteria and according to Rome II criteria, IBS was found in 22% to 45% of children aged 4 to 18 years presenting to tertiary care clinics (Rasquin et al., 2006) . In a Sri Lankan study, 6.23% of schoolchildren aged 10 to 16 years were diagnosed with IBS symptoms as per Rome III criteria with a higher rate in girls (Rajindrajith & Devanarayana, 2012) . The prevalence of functional gastrointestinal disorders, including IBS, remains unclear in pediatric populations and empirical validation of the Rome IV criteria for pediatric patients is needed to address this issue (Schurman, Karazsia, & Friesen, 2017) . Identification of successful management of IBS symptoms to improve school performance and social function in pediatric population would be a significant step forward in pediatric and adolescent populations.
Consistent with the reported prevalence of IBS in the general population, a majority of the identified studies included adults with predominantly more females across all samples. The review findings support that most SM interventions are effective in improving IBS health outcomes including increased quality of life and reduced severity of symptoms. Theory-driven studies are needed to further investigate mechanisms involved in SM knowledge and behavioral changes. Biomarkers, genetic characteristics, and gut microbiome patterns and functions may provide additional information to tailor interventions and evaluate SM intervention effectiveness. Finally, pediatric IBS population (and their family members) needs to be included in future SM interventional studies.
Some limitations should be considered in evaluating the findings from this review. The included studies were highly heterogeneous in study design, sample sizes, interventions, outcome measures, and follow-up duration. Some of the studies did not have a control group, had a small sample size, and/or had a low recruitment rate and high attrition rate, which may have influenced the reported findings. The content and format of the SM intervention program and outcome measurements in the reviewed studies were also diverse, with very few studies reporting on the different types of medical or alternative treatment(s) being used by participants. While it may be assumed that SM interventions are adaptable across different IBS populations, there is not enough evidence to support a specific IBS-SM program recommendation in clinical practice.
A robust body of research has accumulated on the benefits of SM interventions for improving IBS symptoms and quality of life over the short term. Longer term studies are needed to examine sustainability of IBS symptom SM, health behavior change and quality of life. Suggestions for improving the study of SM in individuals with IBS include using standardized symptom measures, including measures of health behavior change, evaluating biological outcomes to identify mechanisms of symptom variations, expanding and tailoring interventions for pediatric and adolescent individuals with IBS, and tracking longer term outcomes, including quality of life and health care costs.
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